These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25622691)

  • 21. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
    Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
    Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms.
    Sheth KN; Shah N; Morovati T; Hermann LD; Cronin CA
    Neurocrit Care; 2012 Oct; 17(2):199-203. PubMed ID: 22752394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients.
    Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular extension of intracerebral hemorrhage during intravenous thrombolysis.
    Harston GW; Tee YK; Jones M; Payne S; Pope G; Sheerin F; Kennedy J
    Cerebrovasc Dis; 2013; 36(4):324-5. PubMed ID: 24193034
    [No Abstract]   [Full Text] [Related]  

  • 26. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score.
    Al-Khaled M; Langner B; Brüning T
    Acta Neurol Scand; 2016 Apr; 133(4):239-44. PubMed ID: 26033162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorrhagic complications of thrombolytic therapy.
    Vujković Z; Racić D; Miljković S; Dajić V
    Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.
    Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J;
    Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry.
    Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Endo K; Miyagi T; Osaki M; Minematsu K; Toyoda K
    Stroke; 2012 Jan; 43(1):253-5. PubMed ID: 21960585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation.
    Brunner F; Tomandl B; Schröter A; Mellinghoff C; Haldenwanger A; Hildebrandt H; Kastrup A
    Eur J Neurol; 2011 Dec; 18(12):1407-11. PubMed ID: 21672089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic intracerebral and systemic hemorrhage after stroke thrombolysis in patients taking ticagrelor.
    Lo KY; Biby S; Sethi P; Campbell BC
    Int J Stroke; 2016 Aug; 11(6):NP71-2. PubMed ID: 27145796
    [No Abstract]   [Full Text] [Related]  

  • 37. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage.
    Cucchiara B; Kasner S; Tanne D; Levine S; Demchuk A; Messe S; Sansing L; Lees K; Lyden P;
    Int J Stroke; 2011 Apr; 6(2):109-11. PubMed ID: 21371270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Seet RC; Zhang Y; Moore SA; Wijdicks EF; Rabinstein AA
    Stroke; 2011 Aug; 42(8):2333-5. PubMed ID: 21659639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 40. Symptomatic Hemorrhage Risks in Stroke Thrombolysis: aDAPTing to Real-World Practice.
    Prabhakaran S; Romano JG
    JAMA Neurol; 2024 Jul; 81(7):689-691. PubMed ID: 38767927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.